RxDoctor Payments Data

David Song, MD

Interventional Cardiology · New York, NYNPI 1932553013

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (44.4%), food and beverage and grants — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Medtronic at 37.3% of the total. 2025 is the largest year on record at $18,455, more than ten times the $698 reported in 2021.

$42,442in general payments, 2019–2025

Across 326 payments — averaging $130.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$16K
  • Abbott$9K
  • Shockwave Medical, Inc$7K
  • Boston Scientific$3K
  • Philips North America LLC$1K
  • Endologix LLC$1K
  • plus $5K from 21 others

What the payments were for

  • Consulting fees$1,1003%
  • Grants$4,84911%
  • Travel & lodging$18,85244%
  • Food & beverage$17,45041%
  • Education$1910%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,442 in reported general payments places this provider in the 80th percentile of 382 interventional cardiology providers in New York.

See all interventional cardiology providers in New York →

Medicare billing

Part B allowed, 2024
$9,805
Medicare patients
33
Services billed
64

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →